Publication

Article

Pharmaceutical Technology

Pharmaceutical Technology-12-02-2004
Volume28
Issue 11

Safety Problems Roil Pharma and FDA

Author(s):

Jill Wechsler

Blockbuster drugs turn out to be risky business, while contamination problems shut down flu vaccine production.

External Link - article-137410.pdf

Articles in this issue
Acceptable Analytical Practices for Dissolution Testing of Poorly Soluble Compounds
The Preparation and Evaluation of Albendazole Microspheres for Colonic Delivery
In the Spotlight-December 2004
In Between the Light and the Dark: Developments in Photosensitive Pharmaceuticals
Safety Problems Roil Pharma and FDA
December 2004
Robust CRO Market Is Driving New Merger and Acquisition Activity
The Seventh Annual International Employment Survey
Pharmaco-Fakery

Newsletter

Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.

Subscribe Now!
Related Videos
US tariff rate rising , trade policy , business graph and dollars banknote , tax calculation change | Image Credit: © janews094 - stock.adobe.com
Related Content
Futuristic health tech. A smartwatch projects a holographic health dashboard, providing real-time body analytics and vital signs monitoring anytime, anywhere. | Image Credit: © woravut - stock.adobe.com
August 5th 2025

How FDA’s ISTAND Initiative Supports Innovative Tools in Drug Discovery and Development

Patrick Lavery
The program has been transitioned to a permanent pathway that is designed to support innovative tools like artificial intelligence, wearables, and biomarkers in drug development and trials.
Drug Solutions Podcast: Growth and Advancements in Fill/Finish
August 5th 2025

Drug Solutions Podcast: Growth and Advancements in Fill/Finish

Felicity Thomas
In this episode, Hanns-Christian Mahler from ten23 Health chats about the advances in fill/finish.
Kratom or Mitragyna speciosa on natural background. | Image Credit: © wasanajai - stock.adobe.com
August 5th 2025

FDA Seeks Scheduling Action to Control Harmful Kratom Plant Byproduct

Patrick Lavery
7-OH and the leaf of the kratom plant are not analogous, but as the former is a derivative of the latter, it has opioid-like qualities that make its susceptibility to abuse concerning.
Drug Solutions Podcast: All About Data: Looking at the EHDS in More Detail
August 5th 2025

Drug Solutions Podcast: All About Data: Looking at the EHDS in More Detail

Felicity Thomas
In this episode, Alexander Natz from EUCOPE chats about the European Health Data Space.
automatic stainless steel pharmaceutical fermenter | Image Credit: ©gen_A - stock.adobe.com
August 5th 2025

In-line UV Spectrometry Monitoring in Cleaning Validation

John Schallom Brian Bosso Paul Lopolito Katie Frey Amy Thanavaro
The authors performed interference and enhancement testing using a formulated alkaline and acid cleaner, as well as common biopharmaceutical process residues.
Landkarte *** Europa | Image credit: ©beugdesign - Stock.adobe.com
August 5th 2025

EMA Encourages Use of New Approach Methodologies to Reduce Animal Testing

Cheryl Barton
EMA is phasing out animal testing and is asking pharmaceutical companies to use new approach methodologies.